Navigation Links
Inogen One G3 Found Significantly More Versatile in Portable Oxygen Concentrator Comparison Report
Date:6/13/2013

SANTA BARBARA, Calif., June 13, 2013 /PRNewswire/ -- Inogen, Inc., a manufacturer and accredited homecare provider of oxygen therapy equipment and services, today announced that the 4.8 pound Inogen One® G3 portable oxygen concentrator (POC) was reviewed as the top performer in many categories among four portable oxygen concentrators in a recent report by an independent third party testing service with expertise in respiratory products, administered by Strategic Dynamics Inc.

(Photo:  http://photos.prnewswire.com/prnh/20130613/LA31751-a)

(Logo:   http://photos.prnewswire.com/prnh/20130613/LA31751LOGO-b)

The methods and results of the study were published in a white paper titled "Comparison of Four Under 5 lb. Portable Oxygen Concentrators." The purpose of the study, according to the report, was to "measure and compare the performance of four commercially available POCs in terms of their oxygen production, purity and delivery to a simulated patient as a function of breathing frequency." Among the POCs tested, the Inogen One G3 ranked the highest in terms of overall performance.

The study's findings highlight two key factors: one) how much oxygen is delivered at each breathing frequency/setting, and two) the concentrators' ability to compensate for breathing changes. Each concentrator was tested on a number of clinical criteria, and the Inogen One G3 excelled in every key clinical factor tested including pulse flow, pulse timing, trigger pressure, and pulse delay.

The summation of all the tests conducted showed the Inogen One G3 to be the highest performing POC in oxygen production and versatility:

"In translating these data to potential clinical applications, the Inogen One® G3 produces more oxygen, can maintain oxygen delivery for a higher range of patient breathing rates and is therefore significantly more versatile in managing the variability of patient oxygen demand throughout different activities."

"Providing oxygen therapy products that are both clinically efficacious and patient preferred are the core values behind the Inogen brand," said Byron Myers, Inogen Co-Founder and VP of Marketing.  "We're pleased that the research conducted by Strategic Dynamics highlights the clear cut differences in clinical application of the featured POCs and that the Inogen One G3 has been recognized as superior in these key areas."

The Inogen One G3 portable oxygen concentrator was released in the Fall of 2012, and is the smallest and lightest oxygen concentrator that Inogen carries.  At only 4.8 pounds, the Inogen One G3 has four flow settings and produces more oxygen per minute than all of the other portable concentrators reviewed in the study.

About Inogen:

Inogen is innovation in oxygen therapy. Our mission is to improve freedom and independence for oxygen therapy patients through innovative products and services.  As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior service to those users in their homes.  For more information, visit the Company's website at www.inogen.net or the product website at www.inogenone.com


'/>"/>
SOURCE Inogen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
2. American Academy of Family Physicians Foundation Launches Cities for Life
3. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
4. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
5. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
6. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
7. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
8. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
9. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
10. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
11. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):